Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Primary total hip arthroplasty with a porous-coated cementless acetabular component continues to provide “durable fixation at 20 years postoperatively,” orthopedic surgeons from Rush…
NEW YORK (Reuters Health) – Contraception, or different reproductive patterns related to contraceptive methods, may affect the risk of some types of cancer, according to findings from the…
M. Bruce Shields, MD, at the Yale Eye Center, discusses laser treatment options for Glaucoma. For more information on this physician, please visit: M. Bruce Shields MD References…
Kathleen M. Stoessel, MD, Director Medical Retina Sub-Section, Yale Eye Center, discusses the classifications of the retinopathy of prematurity, a disorder of developing retinal blood vessels in the…
Jack Stern, MD, PhD, Neurosurgeon and Spine Specialist, discusses the most common surgical procedures for lumbar back pain A microdiscectomy is the most common surgical procedure in the…
Jack Stern, MD, PhD, Neurosurgeon and Spine Specialist, discusses how to approach teaching patients how to sit, walk and lift properly, using the aid of allied health professionals…
Jack Stern, MD, PhD, Neurosurgeon and Spinal Specialist, discusses the challenges in using an artificial lumbar disc. Artificial lumbar disc insertion to stabilize L3-4 and L4-5 is possible…
Jack Stern, MD, PhD, discusses the indications for the use of artificial cervical discs replacing the need for cervical spinal fusion. 1.The artificial cervical disc is a relatively…
NEW YORK (Reuters Health) – Elderly individuals with cognitive impairment may be more likely than those with intact cognitive function to have early age-related macular degeneration (AMD), according…
NEW YORK (Reuters Health) – Long-term adjuvant therapy with pegylated interferon alfa-2b (PEG-IFN-alpha-2b) for advanced melanoma improves recurrence-free survival, investigators report in an early online release from the…
